Additionally, developing sensitive diagnostic tools to detect breast cancer early, tailoring treatment plans based on tumor biology, hormonal receptor status, and patient characteristics, and evaluating the impact of various treatments on fetal health are essential steps. This evidence concerns the gene NR4A1 and breast cancer.